Related Experiment Video
Updated: Mar 21, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Sulfasalazine: A rare cause of acute eosinophilic pneumonia
P Nadarajan1, A Fabre2, E Kelly1
1Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.
Abstract:
Sulfasalazine is a compound of 5-aminosalicylic acid (5-ASA) and sulfapyridine joined by an azo bond. It is a widely used drug in the treatment of chronic inflammatory bowel disease. Fatal toxicity of sulfasalazine arises from its effects on the bone marrow and the resulting blood dyscrasias. Pulmonary toxicity from sulfasalazine is a rather rare finding. Here, we present the case of a patient who developed acute eosinophilic pneumonia with sulfasalazine use.
More Related Videos
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Acute Pyelonephritis I: Introduction
Atypical Pneumonia
Acute Pyelonephritis II: Diagnostic Studies and Management
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

